Press Releases about Alpine Immune Sciences Inc
![](https://mms.businesswire.com/media/20231012528450/en/1405071/5/AIS-Logo.jpg)
![](https://mms.businesswire.com/media/20231004890064/en/1405071/5/AIS-Logo.jpg)
![](https://mms.businesswire.com/media/20230912367677/en/1405071/5/AIS-Logo.jpg)
![](https://mms.businesswire.com/media/20230905389290/en/1405071/5/AIS-Logo.jpg)
Alpine Immune Sciences to Participate in Two Upcoming Healthcare Conferences
September 05, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230905141116/en/1405071/5/AIS-Logo.jpg)
![](https://mms.businesswire.com/media/20230830888628/en/1405071/5/AIS-Logo.jpg)
![](https://mms.businesswire.com/media/20230822041212/en/1405071/5/AIS-Logo.jpg)
![](https://mms.businesswire.com/media/20230814825100/en/1405071/5/AIS-Logo.jpg)
![](https://mms.businesswire.com/media/20230519005392/en/1405071/5/AIS-Logo.jpg)
![](https://mms.businesswire.com/media/20230511005907/en/1405071/5/AIS-Logo.jpg)
![](https://mms.businesswire.com/media/20230501005661/en/1405071/5/AIS-Logo.jpg)
![](https://mms.businesswire.com/media/20230323005680/en/1405071/5/AIS-Logo.jpg)
![](https://mms.businesswire.com/media/20230320005640/en/1405071/5/AIS-Logo.jpg)
![](https://mms.businesswire.com/media/20230316005751/en/1405071/5/AIS-Logo.jpg)
![](https://mms.businesswire.com/media/20230315005827/en/1405071/5/AIS-Logo.jpg)
![](https://mms.businesswire.com/media/20230228006417/en/1405071/5/AIS-Logo.jpg)
![](https://mms.businesswire.com/media/20230209005742/en/1405071/5/AIS-Logo.jpg)
![](https://mms.businesswire.com/media/20221122005816/en/1405071/5/AIS-Logo.jpg)
![](https://mms.businesswire.com/media/20221114006012/en/1405071/5/AIS-Logo.jpg)
![](https://mms.businesswire.com/media/20221107006061/en/1405071/5/AIS-Logo.jpg)
Alpine Immune Sciences to Report Third Quarter 2022 Financial Results
November 07, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20221103006175/en/1405071/5/AIS-Logo.jpg)
![](https://mms.businesswire.com/media/20221103005542/en/1405071/5/AIS-Logo.jpg)
![](https://mms.businesswire.com/media/20221026006010/en/1405071/5/AIS-Logo.jpg)
![](https://mms.businesswire.com/media/20221024005368/en/1405071/5/AIS-Logo.jpg)
![](https://mms.businesswire.com/media/20220920006312/en/1405071/5/AIS-Logo.jpg)
Alpine Immune Sciences Announces Pricing of $100 Million Public Offering
September 20, 2022
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Alpine Immune Sciences Announces Proposed Public Offering
September 20, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220912005897/en/1405071/5/AIS-Logo.jpg)
![](https://mms.businesswire.com/media/20220906006039/en/1405071/5/AIS-Logo.jpg)
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.